BCPC

Balchem Corporation

NASDAQ

Add Alert

BCPC

Balchem Corporation

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

whytestocks Free

08/01/20 8:03 AM

Post #41

News: $BCPC Balchem Corp (BCPC) Q2 2020 Earnings Call Transcript

Image source: The Motley Fool. Balchem Corp (NASDAQ: BCPC) Q2 2020 Earnings Call Jul 31, 2020 , 11:00 a.m. ET Operator Continue reading

Read the whole news BCPC - Balchem Corp (BCPC) Q2 2020 Earnings Call Transcript

ranchhand71 Free

12/26/17 9:15 AM

Post #40

At Curemark the Blüm Study, its second Phase 3 clinical trial to evaluate the safety and efficacy of CM-AT in children aged 3-8 with autism should soon be concluded..will have positive impact on Balchem as they are a key supplier?

Penny Roger$ Free

05/01/12 7:12 AM

Post #39

~ Wednesday! $BCPC ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $BCPC ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.

http://stockcharts.com/h-sc/ui?s=BCPC&p=D&b=3&g=0&id=p88783918276&a=237480049

http://stockcharts.com/h-sc/ui?s=BCPC&p=W&b=3&g=0&id=p54550695994

~ Google Finance: http://www.google.com/finance?q=BCPC
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=BCPC#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=BCPC+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=BCPC
Finviz: http://finviz.com/quote.ashx?t=BCPC
~ BusyStock: http://busystock.com/i.php?s=BCPC&v=2

<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=BCPC >>>>>>

http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Penny Roger$ Free

05/01/12 7:12 AM

Post #38

Re: #34: @metropick - Ha! I was right about this pick...

Penny Roger$ Free

02/25/12 6:30 AM

Post #37

Re: #36: @Penny Roger$ - This stock used to trade under a quarter.

~ Monday! $BCPC ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $BCPC ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.

http://stockcharts.com/h-sc/ui?s=BCPC&p=D&b=3&g=0&id=p88783918276&a=237480049

http://stockcharts.com/h-sc/ui?s=BCPC&p=W&b=3&g=0&id=p54550695994

~ Google Finance: http://www.google.com/finance?q=BCPC
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=BCPC#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=BCPC+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=BCPC
Finviz: http://finviz.com/quote.ashx?t=BCPC
~ BusyStock: http://busystock.com/i.php?s=BCPC&v=2

<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=BCPC >>>>>>

http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Penny Roger$ Free

02/14/12 10:51 PM

Post #36

This stock used to trade under a quarter.

Penny Roger$ Free

02/14/12 10:44 PM

Post #35

Re: #34: @metropick - Ha! I was right about this pick...

BCPC hitting scanner

metropick

07/09/08 12:04 AM

Post #34

Ha! I was right about this pick...

metropick

10/22/07 8:48 PM

Post #33

Balchem Ranks #51 on Forbes 200 Best Small Companies List

http://www.forbes.com/lists/2007/23/biz_07200best_Balchem_4ES2.html

Ranking
5-Yr Avg ROE 50
Sales 161
Profits 157
Market Value 144
12-Mos Sales Growth 43
12-Mos EPS Growth 138
5-Yr Sales Growth 104
5-Yr EPS Growth 143

2007 P/E Estimate 23
2008 P/E Estimate 20
Enterprise Value 3/EBITDA 15

metropick

10/22/07 8:43 PM

Post #32

Q3 EARNINGS CALL NOV 5 at 2 PM EST...

http://biz.yahoo.com/pz/071022/129302.html
Press Release Source: Balchem Corporation
Balchem Corporation Announces Third Quarter 2007 Results and Quarterly Conference Call On November 5, 2007 At 2:00 PM ET

Monday October 22, 2:00 pm ET

NEW HAMPTON, N.Y., Oct. 22, 2007 (PRIME NEWSWIRE) -- Balchem Corporation (NasdaqGS:BCPC - News) today announced that a conference call will be held on Monday, November 5 at 2:00 PM Eastern Time (ET) to review third quarter and year-to-date 2007 results. Dino A. Rossi, President and CEO, and Frank Fitzpatrick, Chief Financial Officer, will host the call.
Quarterly results will be released to the market on Monday, November 5, at 9:30 AM (ET). The press release, and its accompanying financial exhibits, will also be available on the Company website, http://www.balchem.com, prior to the conference call.

We invite you to listen to the call by dialing toll-free (877) 407-8289 (Event #8) five minutes prior to the scheduled start time of the conference call. The conference call will be available for digital replay through Friday, November 9. To access the replay of the conference call, dial (877) 660-6853, use account #298 and conference ID#259297. Both account and conference ID numbers are required for replay access.

About Balchem Corporation

Balchem Corporation consists primarily of three business segments: ARC Specialty Products, Encapsulated/Nutritional Products, and BCP Ingredients, our unencapsulated feed supplements segment. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The Encapsulated/Nutritional segment provides proprietary microencapsulation solutions to an expanding variety of applications. BCP Ingredients manufactures and supplies choline chloride and derivatives used primarily in the poultry and swine industries.

Contact:
Balchem Corporation
Karin McCaffery, Executive Administration Manager
845-326-5600
kmccaffery@balchemcorp.com

metropick

09/30/07 10:09 PM

Post #30

Man, I have had a blast flipping this stock while keeping a good portion of my long term holdings. I can't believe how easy this has been...

metropick

09/14/07 2:55 PM

Post #29

Good entry here, as we see a doji to symbolize a turn up. The MACD is also turing up... adding more at $18.28

metropick

08/29/07 5:27 PM

Post #28

It looks like we have support at $19.50. Good close today!

metropick

08/24/07 10:02 PM

Post #27

Waiting for a pull back to 18.75 then I will pull the trigger again. This stock channels up and down almost predictably.

metropick

08/20/07 5:11 PM

Post #26

Glad to see we are consistently closing above $20...

metropick

08/19/07 1:04 PM

Post #25

Okay folks - we usually split 3 for 2 around these levels...

metropick

08/15/07 12:04 PM

Post #24

Since this board's inception, BCPC has outperformed the S&P 500 by 7.6%... not too shabby!

metropick

08/06/07 12:53 PM

Post #23

Re: #22: @metropick - You got me. Every long wil say their

Can you believe the volatility of this stock!? Holy smokes!

metropick

08/05/07 11:56 AM

Post #22

Re: #21: @autoprt - how come no one's here this seems like

You got me. Every long wil say their stocks are undervalued. But I truly believe this is the case for Balchem. They are the global market leader in Choline Chloride and have been working with major pharma companies to may begin working on delivery technology of existing FDA approved drugs. Good stuff. Undervalued until we hit $24... or get a buyout (one can only hope!)

Regards, and thanks for posting!

m

autoprt

08/04/07 4:32 AM

Post #21

how come no one's here this seems like a good stock to have a little, the price is good and there is activity.

metropick

08/01/07 10:06 AM

Post #20

Blachem BEATS EPS & Revenue Estimates

http://www.reuters.com/article/marketsNews/idUKWNAS921720070801?rpc=44

EPS (diluted) Latest 0.22 Yr-ago qtr 0.17
Net (million) Latest 4.1 Yr-ago qtr 3.1
Net sales (million) Latest 44.4 Yr-ago qtr 25.1

Reuters Estimates: EPS $0.20, revenue $37.9 million.

metropick

08/01/07 9:36 AM

Post #19

Re: #18: @metropick - Balchem Earnings Call This Morning @ 9:30 EST...

Nix the 9:30 time - It's at 2 pm!!! em

metropick

08/01/07 8:41 AM

Post #18

Balchem Earnings Call This Morning @ 9:30 EST...

Listen to the call by dialing toll-free (877) 407-8289 (Event #8) five minutes prior to the scheduled start time of the conference call. The conference call will be available for digital replay through Monday, August 6. To access the replay of the conference call, dial (877) 660-6853, use account #298 and conference ID#249459. Both account and conference ID numbers are required for replay access.

metropick

07/19/07 8:41 PM

Post #17

Balchem Announces Q2 Conference Call August 1

http://biz.yahoo.com/pz/070719/123316.html
Balchem Corporation Announces Quarterly Conference Call Second Quarter 2007 Results August 1, 2007 Time: 2:00 PM ET

NEW HAMPTON, N.Y., July 19, 2007 (PRIME NEWSWIRE) -- Balchem Corporation (NasdaqGS:BCPC - News) today announced that a conference call will be held on Wednesday, August 1, at 2:00 PM Eastern Time (ET) to review second quarter 2007 results. Dino A. Rossi, President and CEO, and Frank Fitzpatrick, Chief Financial Officer, will host the call.
Quarterly results will be released to the market on Wednesday, August 1, at 9:30 AM (ET). The press release, and its accompanying financial exhibits, will also be available on the Company website, http://www.balchem.com, prior to the conference call.

We invite you to listen to the call by dialing toll-free (877) 407-8289 (Event #8) five minutes prior to the scheduled start time of the conference call. The conference call will be available for digital replay through Monday, August 6. To access the replay of the conference call, dial (877) 660-6853, use account #298 and conference ID#249459. Both account and conference ID numbers are required for replay access.

metropick

07/06/07 3:28 PM

Post #16

TheStreet.com VIDEO of BCPC Top-5 Pick
http://videoplayer.thestreet.com/thumblistgrid.aspx?siteId=cf27bf02-65ef-4396-9544-41f1ebd92bdb&...

metropick

07/06/07 12:54 PM

Post #15

TheStreet.com Rates Balchem as a Top-5 Small Cap AGAIN

http://www.thestreet.com/_yahoo/newsanalysis/ratings/10366521_2.html

"Balchem is a chemical company that makes specialty performance products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. It has been rated buy since May 2005.

The company has demonstrated solid stock price performance and growth in earnings per share and revenue. It has a largely solid financial position with reasonable debt levels by most measures and expanding profit margins. TheStreet.com Ratings believes these strengths outweigh the company's somewhat disappointing return on equity."

metropick

06/12/07 9:18 PM

Post #14

NEW PRICE TARGET JUSTIFICATION NOW IN I-BOX ABOVE! em

metropick

06/12/07 8:54 PM

Post #13

Bought more shares on weakness today at $17.77 just before close.

This is like taking candy from a baby.

metropick

06/11/07 3:27 PM

Post #12

We have seen a healthy restablization of share price around $18.40. I think we ratchet upwards from here, as we are trading at low multiples of p/e & peg relative to competitors. Furthermore, the majority choline market share Balchem enjoys still is not fully priced in the shares. Current 1yr target is $26.

metropick

06/04/07 10:59 PM

Post #11

BCPC to da moon in 2007. Bought more on the pull back into the $17s.

metropick

05/09/07 9:56 PM

Post #10

Balchem Announces Record Earnings in Q1 2007

metropick

05/06/07 11:12 PM

Post #9

BCPC: VIDEO Top 5 Small-Cap Stocks

http://videoplayer.thestreet.com/?clipId=1373_10354964&channel=Market+Strategy&cm_ven=YAHOO&...

metropick

05/06/07 11:10 PM

Post #8

BCPC: TheStreet.com's Top Five Small-Cap Stocks

http://www.thestreet.com/_yahoo/newsanalysis/ratings/10354863.html?cm_ven=YAHOO&cm_cat=FREE&...

metropick

05/01/07 11:06 AM

Post #7

Balchem Completes Acquisition

http://www.balchem.com/core/newsletter_details.asp?ArticleID=323
Balchem Completes Acquisition of Akzo Nobel’s European-based Choline Chloride and Methylamines Businesses at Marano Ticino, Italy

New Hampton, New York. May 1, 2007. Balchem Corporation (NASDAQ:BCPC) today announced the completion of its acquisition of the European-based choline chloride and methylamines businesses of Akzo Nobel Chemicals S.p.A. in Marano Ticino. Balchem and Akzo Nobel originally announced this acquisition on April 2, 2007. This facility and business will be operated by Balchem Italia, S.r.l. and employs approximately 75 people in Marano Ticino. In addition, a three person sales force operating out of Balchem Trading B.V. in the Netherlands will have primary responsibility for the marketing, sales and distribution of certain products produced at the facility. In 2006, the Akzo Nobel Marano Ticino business had approximately $35 million dollars (U.S.) in sales.

Balchem is a worldwide leader in the production and sales of various choline chloride products, which are nutritional additives to animal feed and human food products. Methylamines are a primary building block for the manufacture of choline products and have several other chemical applications.

Dino Rossi, Balchem’s President, CEO and Chairman added, “The closing of this transaction marks a tremendous step forward in the evolution and growth of Balchem. This acquisition provides a direct platform for Balchem to meet the growing market needs of methylamines, choline chloride and derivative products for customers via improved global sourcing, regulatory support, marketing and distribution capabilities.”

For more details regarding the closing of this transaction, including the provisional purchase price, see Balchem's Form 8-K filing to be submitted to US Securities and Exchange Commission (www.sec.gov).

metropick

04/26/07 11:14 PM

Post #6

Re: #5: @metropick - 6 straight trading days of equal or better

Make it 7! em

metropick

04/25/07 4:07 PM

Post #5

6 straight trading days of equal or better closing price.

I stand by my target of $29 for this stock, with an upside potential as high as $36.

metropick

04/24/07 8:11 PM

Post #4

Re: #3: @metropick - Balchem Corporation to Purchase the Marano Ticino Choline

My favorite part of this article is: "This revenue, when added to Balchem's 2006 result and its other acquisition in 2007, raises Balchem revenues on a pro forma basis for 2006 to approximately $175 million from $101 million."

Taking into account purely organic growth & identical profit margins, based on past data (see chart in iBox 2004-2006), I am looking for earnings of over $27 million (or $1.56/share), which would put today's p/e at 12. A correction to the current p/e would put this stock at $29/share.

Not a bad rate of return!!! See ya there!!!

metropick

04/24/07 12:43 AM

Post #3

Balchem Corporation to Purchase the Marano Ticino Choline Chloride and Methylamines Business of Akzo Nobel

A follow up from my last post...
http://www.balchem.com/core/newsletter_details.asp?ArticleID=319
New Hampton, New York, April 2, 2007 - Balchem Corporation (NASDAQ: BCPC) today announced that its European subsidiary, Balchem, B.V. entered into an agreement under which it will acquire the choline chloride and methylamines businesses located in Marano Ticino, Italy from Akzo Nobel Chemicals S.p.A. Akzo Nobel is a global leader in the chemical industry, and its Marano Ticino operation employs approximately eighty people, manufacturing and distributing choline, methylamines and derivative products to customers around the world.

"This acquisition provides a production platform that will enable us to better serve the expanding worldwide human and animal choline chloride demand and it also adds a direct commercial European presence, which we now deem necessary. In addition to choline nutritional products, we gain access to production and technology for methylamines, metam sodium and other products for various industrial applications. This platform should provide many opportunities for Balchem to leverage its global growth plans,” said Dino A. Rossi, President, CEO and Chairman of the Board of Directors of Balchem.

In 2006, this Akzo operation realized approximately US $35 million in revenue. This revenue, when added to Balchem's 2006 result and its other acquisition in 2007, raises Balchem revenues on a pro forma basis for 2006 to approximately $175 million from $101 million.

Choline chloride is an essential nutrient for optimum animal growth, and is integral in building, regulating, and maintaining cell membrane integrity and porosity. It also acts as a lipotropic agent, which aids in the utilization and outward transport of fat in the liver. Choline chloride and its derivatives are also used in many other industrial applications. Methylamines are used as raw materials for the production of choline chloride and also widely used in many chemical and industrial applications.

metropick

04/24/07 12:42 AM

Post #2

Balchem Corporation Purchases Certain Business Assets of Chinook Global Limited

With this acquisition, I think Balchem will become the primary choline (vitamin B4) producer in North America... Also, they just announced earlier this month that they would be purchasing Akzo's choline / methyl-amines business in Italy... thus vastly increasing their global market share of choline in just the past few weeks.

Good stuff. Good stuff indeed.

http://www.balchem.com/core/newsletter_details.asp?ArticleID=316
New Hampton, New York - March 19, 2007 - Balchem Corporation (NASDAQ: BCPC) today announced that its subsidiary, BCP Ingredients, Inc. acquired certain choline chloride business assets of Chinook Group Limited of Sombra, Ontario, Canada. Financial terms will be disclosed in SEC filings relating to the transaction.

The acquisition will be integrated into BCP Ingredients’ existing choline chloride manufacturing operations in Verona, Missouri and St. Gabriel, Louisiana. “We are excited at the prospect of enhancing our ability to service the animal nutrition marketplace from our strategically located facilities. Global market dynamics require suppliers to gain scale in order to effectively and economically produce and distribute quality product. Our focused efforts on choline will enable us to contribute to the development of efficient, high performance diets formulated by nutritional experts," said Balchem President and CEO, Dino Rossi. "This acquisition is one more building block in our growth strategy for the animal nutrition and health industry, and a wonderful opportunity for Balchem to implement, and for the consumer to realize, more fully, our synergies which are derived across multiple integrated business segments.”

Choline chloride is an essential nutrient for optimum animal growth, and is integral in building, regulating, and maintaining cell membrane integrity and porosity. It also acts as a lipotropic agent, which aids in the utilization and outward transport of fat in the liver. Choline and choline derivatives are also used in many other industrial applications.

metropick

04/23/07 10:59 AM

Post #1

Welcome to the Balchem Corporation discussion board!

After taking a look under the hood of this very rapidly growing company, I am confident that folks will realize the fanastic synergies and the market positions this company has gained a foothold into.

Looking for great things out of BCPC in the next few years.

Much more info to come in the iBox.

Regards,

Metro

Balchem Corporation (BCPC)

Followers	1	Posters	5
Posts (Today)	0	Posts (Total)	41
Created	04/23/07	Type	Free
Moderators

(expand to full screen)

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the food, nutritional, pharmaceutical, feed and medical sterilization industries. Balchem's reportable segments are strategic businesses that offer products and services to different markets. Balchem presently has three reportable segments: I. Specialty Products The specialty products segment repackages and distributes the following specialty gases: ethylene oxide, blends of ethylene oxide, propylene oxide and methyl chloride. II. Encapsulated / Nutritional Products The encapsulated / nutritional products segment provides microencapsulation, chelation and agglomeration solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance therapeutic performance, taste, processing, packaging and shelf-life. Major end product applications are baked goods, refrigerated and frozen dough systems, processed meats, seasoning blends, confections, nutritional supplementations, pharmaceuticals and animal nutrition. We also market human grade choline nutrient products through this industry segment for wellness applications. III. BCP Ingredients BCP Ingredients manufactures and supplies choline chloride, an essential nutrient for animal health, to the poultry and swine industries. In addition, certain derivatives of choline chloride are also marketed into industrial applications. DATA As can be seen from the chart analysis below, Balchem presents a diverse portfolio, supported by quickly growing earnings across all of its business segments!!!